DNMT3A dysfunction promotes neuroinflammation and exacerbates acute ischemic stroke
MedComm · 2024-07 · 5 (7)
DOI: 10.1002/mco2.652 ↗At a glance
Journal article in MedComm, published online on 2024-07-14. Written by Tian-Jie Lyu and 24 co-authors. Institution: Department of Neurology Beijing Tiantan Hospital Capital Medical University Beijing China. Cited 11 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Ministry of Science and Technology of the People's Republic of China.
Topics: Schlaganfall
Abstract (original language)
Somatic mutations related to clonal hematopoiesis of indeterminate potential (CHIP) are risk factors for stroke. The impact of DNMT3A , the most mutated gene in CHIP, on clinical functional outcomes of acute ischemic stroke (AIS) remains unclear. In a well‐characterized cohort of 8524 ischemic stroke patients, we demonstrated that DNMT3A ‐driven CHIP was significantly associated with neurological disability in these patients. With a stroke mouse model of transient middle cerebral artery occlusion (tMCAO), we demonstrated that DNMT3A protein levels in the brain penumbra increased. The DNMT3A inhibitor RG108 administration amplified neutrophil proliferation in the blood, promoted neutrophil infiltration into the brain penumbra, and exaggerated proinflammatory activation in tMCAO male mice. DNMT3A inhibition also significantly increased infarct volume and worsened neurobehavioral function in tMCAO male mice. In conclusion, DNMT3A somatic mutations are associated with worsened neurological disability in some patients with AIS, potentially through increased neutrophil proliferation and infiltration in the ischemic brain region. These findings suggest a possible mechanism for proinflammatory activation and tissue damage in the affected brain tissue, highlighting the need for further research in this area.
Subjects
Author keywords
Authors and institutions
- Department of Neurology Beijing Tiantan Hospital Capital Medical University Beijing China.
- China National Clinical Research Center for Neurological Diseases Beijing China.
- Center for Metabolic Disease Research Lewis Katz School of Medicine Temple University Philadelphia Pennsylvania USA.
- Department of Biochemistry and Molecular Biology School of Basic Medical Sciences Capital Medical University Beijing China.
- Clinical Center for Precision Medicine in Stroke Capital Medical University Beijing China.
- Advanced Innovation Center for Human Brain Protection Capital Medical University Beijing China.
ORCID profiles: Tian-Jie Lyu
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- Ministry of Science and Technology of the People's Republic of China
Cite
APA
Lyu, T. J., Qiu, X., Wang, Y., Zhang, L., Dai, Y., Wang, X., Zhao, S., Xiang, M., Cui, L., Cheng, S., Liu, Y., Gu, H., Jiang, Y., Meng, X., Wang, Y., Zhao, X., Wang, X., Li, Q., Wang, M., …, & Li, Z. (2024). DNMT3A dysfunction promotes neuroinflammation and exacerbates acute ischemic stroke. MedComm, 5(7). https://doi.org/10.1002/mco2.652
Vancouver
Lyu TJ, Qiu X, Wang Y, Zhang L, Dai Y, Wang X, et al. DNMT3A dysfunction promotes neuroinflammation and exacerbates acute ischemic stroke. MedComm. 2024;5(7). doi:10.1002/mco2.652
BibTeX
@article{Lyu2024,
author = {Lyu, Tian-Jie and Qiu, Xin and Wang, Yubo and Zhang, Ling and Dai, Yalun and Wang, Xuechun and Zhao, Shunying and Xiang, Meilin and Cui, Lu and Cheng, Si and Liu, Yang and Gu, Hongqiu and Jiang, Yong and Meng, Xia and Wang, Yilong and Zhao, Xingquan and Wang, Xianwei and Li, Qian and Wang, Meng and Jiang, Yingyu and Xu, Zhe and Huang, Xinying and Li, Hao and Wang, Yongjun and Li, Zixiao},
title = {DNMT3A dysfunction promotes neuroinflammation and exacerbates acute ischemic stroke},
journal = {MedComm},
year = {2024},
volume = {5},
number = {7},
doi = {10.1002/mco2.652}
}
EUVIMED